Long-Term Treatment Effect With Tildrakizumab in Participants With Plaque Psoriasis
Clinical trial NCT04339595 · TERMINATED
Trial details
- NCT number
- NCT04339595
- Sponsor
- Almirall, S.A.
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-29
- Primary completion
- 2020-07-31
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.